Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
July 16, 20135m 10s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.